novo nordisk oral glp-1 Nordisk's weight-loss pill wins FDA approval Novo Nordisk's weight loss pill

Starting Wednesday, Medicare will help pay for some GLP-1 medications for weight loss

Dana Cohen

Glucagon-like peptide-1 (GLP-1) receptor agonists, especially semaglutide, are associated with a reduced risk for worsening of anxiety and depression that co-oc

Chief amongst the various hormones that are secreted from the EECs is GLP-1, a peptide whose actions result in the regulation of circulating glucose, the

It presents clinical strategies for adverse event mitigation, monitoring recommendations, contraindications, and practical considerations for treatment discontinuation or switching

Genes affect how well semaglutide (Ozympic) and tirzepatide work